ScopusElsevier Scopus
Status
Inactive/Discontinued
Coverage
2017–2023 (also 1991–2015)
Source type
Journal
Open access
No
SJR · SCImago
0.230
Q4 SJR quartile
H-index
62
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Antiviral Chemistry and Chemotherapy
Antiviral Chemistry and Chemotherapy is not currently indexed in Scopus. Published by SAGE Publications Inc..
Checked against the index lists dated .
ISSN 0956-3202Verify ISSN ↗2040-2066Verify ISSN ↗
Publisher: SAGE Publications Inc.
Scopus · Inactive
0
Indexed in
Cost to publish: About US$1,500 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Antiviral Chemistry and Chemotherapy indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2017–2023 (also 1991–2015)).
What is the impact factor of Antiviral Chemistry and Chemotherapy?
Antiviral Chemistry and Chemotherapy has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.230, quartile Q4, with an H-index of 62.
How much does it cost to publish in Antiviral Chemistry and Chemotherapy?
The publisher lists an article processing charge of about US$1,500 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Antiviral Chemistry and Chemotherapy and what is its ISSN?
Antiviral Chemistry and Chemotherapy is published by SAGE Publications Inc. Its print ISSN is 0956-3202 and its online ISSN is 2040-2066.
Is Antiviral Chemistry and Chemotherapy in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Antiviral Chemistry and Chemotherapy open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
Scopus coverage history
Scopus indexed Antiviral Chemistry and Chemotherapy for 32 years, between 1991 and 2023, with 1 year in that span missing. Coverage ended in 2023, 3 years ago, and Scopus now lists the title as inactive.
Is it still publishing? OpenAlex lists 1,014 works and 23,887 citations for the title. Its most recent paper is from 2023, in line with the end of Scopus coverage in 2023, which suggests the journal stopped publishing around then.
How well cited is Antiviral Chemistry and Chemotherapy? — open metrics via OpenAlex
Antiviral Chemistry and Chemotherapy has an h-index of 67 and a 2-year mean of 0 citations per paper (OpenAlex).
67
h-index
0
2-yr mean citations
605
i10-index
1,014
works indexed
23,887
total citations
Publication fee · open access list price, US$
US$1,500
Antiviral Chemistry and Chemotherapy published 2 papers in 2023; its busiest recent year was 2015 with 20. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Who publishes in Antiviral Chemistry and Chemotherapy? — latest 17 articles, 2021–2023
In its latest 17 research articles (2021–2023), authors are most often from Belgium (30.1%), United States (18.4%) and United Kingdom (9.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Antiviral Chemistry and Chemotherapy? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2023. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2023
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from SAGE Publications Inc.
SAGE Publications Inc. has 473 other titles in our data; 422 are currently indexed in Scopus.
Related journals
8 journals Journal Indexed in
Applied Spectroscopy Scopus Q2 WoS SCIE Armed Forces and Society Scopus Q1 WoS SSCI Asia-Pacific Journal of Public Health Scopus Q3 WoS SCIE/SSCI Asian Cardiovascular and Thoracic Annals Scopus Q3 WoS ESCI Asian Journal of Legal Education Scopus Q2 ASN Neuro Scopus Q1 WoS SCIE DOAJ Assessment Scopus Q1 WoS SSCI Assessment for Effective Intervention Scopus Q2 WoS ESCI
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.